| scholarly article | Q13442814 |
| P2093 | author name string | Andrea N Edginton | |
| Len Ritter | |||
| P2860 | cites work | Human UGT2B7 catalyzes morphine glucuronidation | Q28302296 |
| Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDP-glucuronosyltransferase, UGT2B1, in the rat liver | Q28343335 | ||
| Developmental aspects of human hepatic drug glucuronidation in young children and adults | Q28344957 | ||
| Metabolism and kinetics of bisphenol a in humans at low doses following oral administration | Q29615675 | ||
| Dynamics of fat cell turnover in humans | Q29615688 | ||
| Analysis of methylmercury disposition in humans utilizing a PBPK model and animal pharmacokinetic data | Q30651582 | ||
| Cloning and characterisation of the first drug-metabolising canine UDP-glucuronosyltransferase of the 2B subfamily | Q30916936 | ||
| Bisphenol A (BPA) daily intakes in the United States: estimates from the 2003-2004 NHANES urinary BPA data | Q31152700 | ||
| From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools | Q33254667 | ||
| Glucuronidation in humans. Pharmacogenetic and developmental aspects | Q33700129 | ||
| A physiological model for the estimation of the fraction dose absorbed in humans. | Q33980119 | ||
| Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. | Q34836887 | ||
| Toxicokinetic modeling and its applications in chemical risk assessment | Q35057281 | ||
| Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents | Q35624622 | ||
| The Acute Exposure Guideline Level (AEGL) program: applications of physiologically based pharmacokinetic modeling | Q35802386 | ||
| Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs | Q35827012 | ||
| Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. | Q36775268 | ||
| Ontogeny of human hepatic cytochromes P450. | Q36971473 | ||
| Human exposure to bisphenol A by biomonitoring: methods, results and assessment of environmental exposures. | Q37061306 | ||
| The ontogeny of drug metabolism enzymes and implications for adverse drug events | Q37136222 | ||
| Using ontogeny information to build predictive models for drug elimination | Q37189993 | ||
| Protein binding predictions in infants | Q37361786 | ||
| Physiologically based pharmacokinetics of bisphenol A. | Q40472027 | ||
| The growth and development of fat cells in infancy | Q41043843 | ||
| A review of the environmental fate, effects, and exposures of bisphenol A. | Q41753602 | ||
| Maturation and growth of renal function: dosing renally cleared drugs in children | Q42030741 | ||
| A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids | Q42287561 | ||
| Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac | Q43569654 | ||
| Automated on-line column-switching HPLC-MS/MS method with peak focusing for measuring parabens, triclosan, and other environmental phenols in human milk | Q43669321 | ||
| Distribution and unspecific protein binding of the xenoestrogens bisphenol A and daidzein | Q44055532 | ||
| A physiologic model for simulating gastrointestinal flow and drug absorption in rats. | Q44684303 | ||
| Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach | Q45299063 | ||
| Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat. | Q46461608 | ||
| Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. | Q46652706 | ||
| Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods? | Q46906656 | ||
| Adipose tissue fatty acids and size and number of fat cells from birth to 9 years of age--a cross-sectional study in 96 boys | Q47322475 | ||
| Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions | Q48567088 | ||
| Physiologically based pharmacokinetic modelling: a sub-compartmentalized model of tissue distribution. | Q51905139 | ||
| Development and evaluation of a generic physiologically based pharmacokinetic model for children. | Q51933198 | ||
| Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. | Q51975107 | ||
| A mechanistic approach for the scaling of clearance in children. | Q52013911 | ||
| Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. | Q52538617 | ||
| Pharmacokinetic disposition and tissue distribution of bisphenol A in rats after intravenous administration. | Q52541262 | ||
| Nutrient intake by breast-fed infants during the first five days after birth | Q69583271 | ||
| Human Adipose Tissue Composition and Age | Q72517885 | ||
| Prepubertal exposure to compounds that increase prolactin secretion in the male rat: effects on the adult prostate | Q73201546 | ||
| Whole body physiologically-based pharmacokinetic models: their use in clinical drug development | Q81816449 | ||
| Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model | Q83940718 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 645-52 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Environmental Health Perspectives | Q1345904 |
| P1476 | title | Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic model | |
| P478 | volume | 117 |
| Q43423224 | A new approach for regulating bisphenol A for the protection of the public's health |
| Q36665050 | A review of the carcinogenic potential of bisphenol A. |
| Q36910537 | A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam |
| Q28395212 | Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk |
| Q37937047 | An update on computational oral absorption simulation |
| Q36159334 | Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults |
| Q53454406 | Assessment of bisphenol A exposure in Korean pregnant women by physiologically based pharmacokinetic modeling. |
| Q37764483 | Biomonitoring Equivalents for bisphenol A (BPA). |
| Q34060021 | Biomonitoring studies should be used by regulatory agencies to assess human exposure levels and safety of bisphenol A. |
| Q28391005 | Bisphenol A concentrations in maternal breast milk and infant urine |
| Q42704656 | Bisphenol A regulates the estrogen receptor alpha signaling in developing hippocampus of male rats through estrogen receptor |
| Q92589934 | Bisphenol A, Tobacco Smoke, and Age as Predictors of Oxidative Stress in Children and Adolescents |
| Q49551649 | Challenges Associated with Applying Physiologically Based Pharmacokinetic Modeling for Public Health Decision-Making |
| Q61455290 | Characterization of Follicular Atresia Responsive to BPA in Zebrafish by Morphometric Analysis of Follicular Stage Progression |
| Q37595210 | Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive manner |
| Q33579671 | Comparison of toxicity values across zebrafish early life stages and mammalian studies: Implications for chemical testing |
| Q30396069 | Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. |
| Q37308114 | DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk |
| Q24651317 | Does rapid metabolism ensure negligible risk from bisphenol A? |
| Q42361408 | EDCs Mixtures: A Stealthy Hazard for Human Health? |
| Q35234895 | Early Life Metabolism of Bisphenol A: A Systematic Review of the Literature |
| Q36989134 | Enamel defects reflect perinatal exposure to bisphenol A |
| Q28397992 | Environmental factors, epigenetics, and developmental origin of reproductive disorders |
| Q41679927 | Exposure assessment of Bisphenol A intake from polymeric baby bottles in formula-fed infants aged less than one year |
| Q42712956 | Functional UDP-glucuronyltransferase 2B15 polymorphism and bisphenol A concentrations in blood: results from physiologically based kinetic modelling |
| Q41168942 | Human urine and plasma concentrations of bisphenol A extrapolated from pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and semi-physiological pharmacokinetic modeling. |
| Q36513110 | Improving Knowledge about Children's Environmental Health in Northwest China |
| Q38639379 | Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects. |
| Q47990931 | Investigation of an alternative generic model for predicting pharmacokinetic changes during physiological stress |
| Q48647336 | Loss of Hippocampal Oligodendrocytes Contributes to the Deficit of Contextual Fear Learning in Adult Rats Experiencing Early Bisphenol A Exposure |
| Q41498102 | Low-Dose Bisphenol A Increases Bile Duct Proliferation in Juvenile Rats: A Possible Evidence for Risk of Liver Cancer in the Exposed Population? |
| Q36963046 | Neonatal bisphenol A exposure induces meiotic arrest and apoptosis of spermatogenic cells. |
| Q34022159 | Neonatal exposure to bisphenol a and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats |
| Q42374009 | Occupational Exposure to Bisphenol A (BPA): A Reality That Still Needs to Be Unveiled. |
| Q41975490 | Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug |
| Q92010447 | Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative |
| Q47168396 | Prediction of human prenatal exposure to bisphenol A and bisphenol A glucuronide from an ovine semi-physiological toxicokinetic model. |
| Q47148724 | Scientific Opinion on Bisphenol A: evaluation of a study investigating its neurodevelopmental toxicity, review of recent scientific literature on its toxicity and advice on the Danish risk assessment of Bisphenol A |
| Q47156665 | Scientific Opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs |
| Q35799755 | Serial Free Bisphenol A and Bisphenol A Glucuronide Concentrations in Neonates |
| Q36146208 | Serum Bisphenol A Level in Boys with Cryptorchidism: A Step to Male Infertility? |
| Q51057410 | Serum bisphenol A concentration and premature thelarche in female infants aged 4-month to 2-year. |
| Q34553299 | Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats |
| Q48259254 | Simulation of differential drug pharmacokinetics under heat and exercise stress using a physiologically based pharmacokinetic modeling approach |
| Q90393326 | Testing baby bottles for the presence of residual and migrated bisphenol A |
| Q64269124 | The effects of perinatal bisphenol A exposure on thyroid hormone homeostasis and glucose metabolism in the prefrontal cortex and hippocampus of rats |
| Q38234794 | The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events |
| Q34885182 | Unraveling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling |
| Q36721563 | Urinary free bisphenol A and bisphenol A-glucuronide concentrations in newborns |
| Q28382768 | Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A |
| Q37977848 | Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. |